Lemtrada (alemtuzumab)

ALERT-FDA-MULTIPLE SCLEROSIS DRUG LEMTRADA (ALEMTUZUMAB)

From The U.S. Food & Drug Administration FDA warns about rare but serious risks of stroke and blood vessel wall…